Business Immo, the real estate website

Life Sciences

Office 10/07/2023

JLL sets up a Life Sciences team in France

JLL has decided to set up a Life Sciences team in France. At the same time, the corporate real estate consultancy has also joined (...)

Office 06/07/2023

Remake signs two sale & leaseback deals in Spain at an average yield of 7.15 %

Remake is expanding its portfolio in Spain with the acquisition of three buildings through two sale & leasebacks in Catalonia and the Basque Country (...)

Office 14/06/2023

Life Sciences property ready to make its mark in France

Life Sciences real estate - an asset class that encompasses the infrastructure occupied by the pharmaceutical, biotechnology and medical industries - has established itself (...)

Finance 22/05/2023

“For Blackstone, the current dislocation creates opportunities”

Business Immo Global: Can we conclude from the successful fundraising of the Blackstone Real Estate Partners X fund that institutional investors still have a (...)

Finance 13/03/2023

"Each crisis reminds us a little of the fundamentals from which we should not have drifted"

Business Immo: Faced with strong macroeconomic and geopolitical tensions, real estate investors must now deal with a new financial context. How do you interpret (...)

Office 09/03/2023

Life Sciences: Kadans accelerates its pace in France

After completing its first French acquisition in Villejuif at the end of 2022, Kadans Sciences Partners announced in mid-February its second French project, this (...)

Finance 16/02/2023

“We are expecting numerous opportunities to arise in the first half of 2023”

Business Immo: Aviva Investors is rebuilding its presence in France following the sale of Aviva France in the fall of 2021. Where are you (...)

Office 13/02/2023

Kadans Science Partner to develop 14,000 sqm of "tech" space in Paris-Saclay

After making its first real estate acquisition in France last year*, Kadans Science Partner has just signed a promise of sale with the EPA (...)

Finance 09/01/2023

Investing in Europe: how to approach 2023

Some courageous investors and advisors have spoken out since last December and have given us their vision of the markets in which they operate. (...)

Health / Senior 17/11/2022

Oxford Properties and Novaxia sign a first Life Sciences acquisition in Romainville

The "jewel of Romainville" has finally found a new taker. Oxford Properties and Novaxia announced this Thursday the acquisition from Fiminco and Banque des (...)

Finance 27/10/2022

"We are looking to strengthen the resilience of our portfolio"

Business Immo: This time, the page of the Duo towers, inaugurated at the beginning of the fall, is definitively turned?  Karim Habra: The construction is (...)

Health / Senior 09/06/2022

Novaxia plays the diversification card with Life Sciences

Through a co-investment partnership involving €1bn of capital, Novaxia and Oxford Properties have acquired a €2bn investment capacity to be deployed between now and (...)

Office 16/05/2022

Novaxia and Oxford Properties join forces to invest €2bn in French Life Sciences

As part of a co-investment partnership, Novaxia and Oxford Properties intend to raise €1bn of capital in France by 2024 for Life Sciences real (...)

Office 15/04/2022

"Kadans strongly believes the Life Sciences sector is only starting its journey in Europe"

BiTV Interviews welcomes Michel Leemhuis, CEO and Co-owner at Kadans Science Partner. With him, we discuss the new 70,000 sqm building in London developped by his (...)

Finance 01/03/2022

AXA IM Alts raises record c. €18bn of capital in 2021

AXA IM Alts raised a record €18.2bn of capital in 2021, including €10.2bn of third party commitments, reflecting the strong positioning and suitability of (...)

Office 26/07/2021

AXA IM Alts raises €1.9bn for European Life Sciences investments

Paris-based global manager AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily (...)